Wellington Shields Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.4K | Buy |
519
+2
| +0.4% | +$280 | 0.01% | 288 |
|
|
2025
Q4 | $63.5K | Buy |
517
+2
| +0.4% | +$243 | 0.01% | 282 |
|
|
2025
Q3 | $57.2K | Buy |
515
+3
| +0.6% | +$341 | 0.01% | 304 |
|
|
2025
Q2 | $56.8K | Sell |
512
-348
| -40% | -$37K | 0.01% | 292 |
|
|
2025
Q1 | $96.3K | Sell |
860
-233,647
| -100% | -$24.1M | 0.02% | 258 |
|
|
2024
Q4 | $562K | Buy |
234,507
+228,428
| +3,758% | +$20.6M | 0.1% | 141 |
|
|
2024
Q3 | $510K | Buy |
6,079
+1,003
| +20% | +$76.5K | 0.09% | 159 |
|
|
2024
Q2 | $348K | Buy |
5,076
+2,976
| +142% | +$199K | 0.06% | 186 |
|
|
2024
Q1 | $154K | Hold |
2,100
| – | – | 0.03% | 245 |
|
|
2023
Q4 | $170K | Buy |
2,100
+2,086
| +14,900% | +$162K | 0.02% | 234 |
|
|
2023
Q3 | $1.05K | Hold |
14
| – | – | ﹤0.01% | 300 |
|
|
2023
Q2 | $1.08K | Sell |
14
-14
| -50% | -$1.12K | ﹤0.01% | 307 |
|
|
2023
Q1 | $2.32K | Hold |
28
| – | – | ﹤0.01% | 316 |
|
|
2022
Q4 | $2.4K | Buy |
+28
| New | +$2.22K | ﹤0.01% | 308 |
|
|
2022
Q2 | – | Sell |
-150
| Closed | -$9K | – | 307 |
|
|
2022
Q1 | $9K | Buy |
+150
| New | +$9.59K | ﹤0.01% | 311 |
|
|
2018
Q4 | – | Sell |
-4,000
| Closed | -$309K | – | 287 |
|
|
2018
Q3 | $309K | Hold |
4,000
| – | – | 0.05% | 240 |
|
|
2018
Q2 | $283K | Hold |
4,000
| – | – | 0.05% | 251 |
|
|
2018
Q1 | $302K | Hold |
4,000
| – | – | 0.05% | 263 |
|
|
2017
Q4 | $287K | Hold |
4,000
| – | – | 0.04% | 285 |
|
|
2017
Q3 | $324K | Sell |
4,000
-867
| -18% | -$66.3K | 0.05% | 251 |
|
|
2017
Q2 | $344K | Sell |
4,867
-800
| -14% | -$53.2K | 0.06% | 251 |
|
|
2017
Q1 | $385K | Hold |
5,667
| – | – | 0.06% | 232 |
|
|
2016
Q4 | $406K | Sell |
5,667
-1,175
| -17% | -$87.3K | 0.07% | 221 |
|
|
2016
Q3 | $541K | Sell |
6,842
-130
| -2% | -$10.6K | 0.09% | 200 |
|
|
2016
Q2 | $582K | Sell |
6,972
-4,000
| -36% | -$355K | 0.1% | 181 |
|
|
2016
Q1 | $1.01M | Sell |
10,972
-15,850
| -59% | -$1.43M | 0.18% | 118 |
|
|
2015
Q4 | $2.71M | Hold |
26,822
| – | – | 0.46% | 47 |
|
|
2015
Q3 | $2.63M | Sell |
26,822
-470
| -2% | -$52.2K | 0.45% | 40 |
|
|
2015
Q2 | $3.19M | Sell |
27,292
-1,700
| -6% | -$186K | 0.49% | 45 |
|
|
2015
Q1 | $2.85M | Buy |
28,992
+850
| +3% | +$86.3K | 0.43% | 51 |
|
|
2014
Q4 | $2.65M | Sell |
28,142
-13,293
| -32% | -$1.37M | 0.42% | 48 |
|
|
2014
Q3 | $4.41M | Buy |
41,435
+1,085
| +3% | +$106K | 0.73% | 23 |
|
|
2014
Q2 | $3.35M | Buy |
40,350
+3,350
| +9% | +$261K | 0.52% | 33 |
|
|
2014
Q1 | $2.62M | Hold |
37,000
| – | – | 0.45% | 39 |
|
|
2013
Q4 | $2.78M | Sell |
37,000
-700
| -2% | -$48.7K | 0.5% | 34 |
|
|
2013
Q3 | $2.37M | Hold |
37,700
| – | – | 0.45% | 37 |
|
|
2013
Q2 | $1.93M | Buy |
+37,700
| New | +$1.97M | 0.34% | 48 |
|
Other funds holding GILD
VCM
VPM
Wellington Shields Capital Management's GILD Position: Q1 2026 in Review
Wellington Shields Capital Management increased its Gilead Sciences (GILD) stake by 0.39% in Q1 2026, buying an estimated $280 and bringing the position to 519 shares worth $72.4K. The position accounts for 0.01% of the portfolio, ranked #288.
Wellington Shields Capital Management first reported a position in GILD in Q2 2013 and has held it in 37 quarters since. The position peaked at $4.41M in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Wellington Shields Capital Management held 519 shares of Gilead Sciences worth $72.4K as of Q1 2026.
- Wellington Shields Capital Management bought 2 Gilead Sciences shares in Q1 2026, an estimated $280.
- Gilead Sciences made up 0.01% of Wellington Shields Capital Management's portfolio in Q1 2026, its #288 holding.
- Wellington Shields Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 37 quarters since.
- Wellington Shields Capital Management's Gilead Sciences position peaked at $4.41M in Q3 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Wellington Shields Capital Management's 13F filing for Q1 2026, filed 4 May 2026.